Items Tagged ‘CINV’

September 21st, 2015

Varubi Approved for Chemotherapy-Induced Nausea and Vomiting


The United States Food and Drug Administration (FDA) approved the agent Varubi (rolapitant) to be used to prevent delayed phase chemotherapy-induced nausea and vomiting (emesis). Chemotherapy-induced nausea and vomiting (CINV) is a common side effect of treatment with chemotherapy among cancer patients. It can become a serious side effect in that it can cause dehydration, electrolyte […]

View full entry

Tags: chemotherapy-induced, CINV, clinical trial, nausea, Other News Topics (not Types of Cancer), rolapitant, Varubi, vomiting